Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.49% |
| 2 | Technology | 12.13% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Deluxe
DLX
$1.1B
| $3M | ﹤0.01% |
+39,062
| New | +$2.82M |
|
2027
Ares Capital
ARCC
$14.3B
| $3M | ﹤0.01% |
190,909
-1,120,935
| -85% | -$18.2M |
|
2028
Seres Therapeutics
MCRB
$49.7M
| $3M | ﹤0.01% |
14,784
+4,247
| +40% | +$873K |
|
2029
Silicom
SILC
$266M
| $2.99M | ﹤0.01% |
42,660
+16,598
| +64% | +$1.13M |
|
2030
AutoNation
AN
$6.58B
| $2.99M | ﹤0.01% |
+58,234
| New | +$2.95M |
|
2031
Centene
CNC
$32.5B
| $2.99M | ﹤0.01% |
+59,220
| New | +$2.87M |
|
|
NCOM
2032
DELISTED
National Commerce Corporation
NCOM
| $2.97M | ﹤0.01% |
73,795
+58,307
| +376% | +$2.41M |
|
2033
Vanguard Real Estate ETF
VNQ
$39B
| $2.96M | ﹤0.01% |
35,719
-130,829
| -79% | -$11M |
|
2034
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.5B
| $2.95M | ﹤0.01% |
61,616
-1,687
| -3% | -$81.5K |
|
|
CMD
2035
DELISTED
Cantel Medical Corporation
CMD
| $2.95M | ﹤0.01% |
28,636
-58,947
| -67% | -$5.87M |
|
|
SCG
2036
CALL
DELISTED
Scana
SCG
| $2.94M | ﹤0.01% |
+74,000
| New | +$3.31M |
|
2037
Churchill Downs
CHDN
$6.07B
| $2.94M | ﹤0.01% |
+75,882
| New | +$2.75M |
|
|
DPLO
2038
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $2.94M | ﹤0.01% |
146,554
-1,332,660
| -90% | -$26.2M |
|
|
CSII
2039
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.94M | ﹤0.01% |
123,986
-446,895
| -78% | -$11.3M |
|
2040
Stoneridge
SRI
$204M
| $2.93M | ﹤0.01% |
128,245
-276,555
| -68% | -$6.18M |
|
2041
Mammoth Energy Services
TUSK
$153M
| $2.92M | ﹤0.01% |
+148,934
| New | +$2.71M |
|
2042
Walker & Dunlop
WD
$1.39B
| $2.92M | ﹤0.01% |
61,515
+45,042
| +273% | +$2.3M |
|
|
ODP
2043
DELISTED
ODP
ODP
| $2.92M | ﹤0.01% |
82,373
+66,687
| +425% | +$2.31M |
|
|
TIME
2044
CALL
DELISTED
Time Inc.
TIME
| $2.91M | ﹤0.01% |
157,700
-230,200
| -59% | -$3.44M |
|
2045
Five Point Holdings
FPH
$368M
| $2.91M | ﹤0.01% |
206,270
+125,962
| +157% | +$1.72M |
|
2046
Xcel Energy
XEL
$48B
| $2.9M | ﹤0.01% |
60,342
-3,174,158
| -98% | -$158M |
|
2047
LCI Industries
LCII
$2.51B
| $2.9M | ﹤0.01% |
22,315
+9,620
| +76% | +$1.18M |
|
2048
KRONOS Worldwide
KRO
$1.01B
| $2.9M | ﹤0.01% |
112,403
-357,824
| -76% | -$9.37M |
|
2049
Cerus
CERS
$554M
| $2.89M | ﹤0.01% |
+854,342
| New | +$2.89M |
|
2050
John B. Sanfilippo & Son
JBSS
$855M
| $2.89M | ﹤0.01% |
+45,664
| New | +$2.87M |
|
Similar funds
Israel Englander's Q4 2017 Portfolio in Review
As of Q4 2017, Israel Englander held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander deployed $4.49B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Israel Englander's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Israel Englander's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Israel Englander fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Israel Englander's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Israel Englander opened 897 new positions and closed 601 in Q4 2017.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.